Michael Jakupec

Activities

Activities per year 2004 2006 2007 2008 2010 2014 2023

• 92 Poster presentation
• 29 Talk or oral contribution

Activities per year

Search results

• Not the Usual Suspect – an Unexpected Organometallic Product during the Synthesis of a Cytotoxic Platinum(II) Complex

  Thomas Maier (Speaker), Judith Wutschitz (Contributor), Natalie Gajic (Contributor), Alexander Prado-Roller (Contributor), Michaela Hejl (Contributor), Klaudia Cseh (Contributor), Michael Jakupec (Contributor), Mathea Sophia Galanski (Contributor) & Bernhard Keppler (Contributor)

  22 Mar 2023

  Activity: Talks and presentations › Talk or oral contribution › Science to Science

• In vitro investigations on oxaliplatin – a comparison study of resistant and sensitive cells

  Luis Galvez (Speaker), Mate Rusz (Contributor), Michaela Schwaiger-Haber (Contributor), Michael Jakupec (Contributor) & Gunda Köllensperger (Contributor)

  8 Jan 2018

  Activity: Talks and presentations › Talk or oral contribution › Science to Science

• Multicellular spheroids as models and tools in anticancer metallodrug research

  Michael Jakupec (Speaker)

  14 Aug 2017

  Activity: Talks and presentations › Talk or oral contribution › Science to Science

• Multimodal imaging of multicellular tumor spheroids by MALDI-MS and high- resolution LA-ICP-MS

  Sarah Theiner (Speaker), S. Van Malderen (Contributor), M. Holzlechner (Contributor), A. Svirkova (Contributor), T. Van Acker (Contributor), Anton Legin (Contributor), Michael Jakupec (Contributor), Bernhard Keppler (Contributor), Martina Marchetti-Deschmann (Contributor), Frank Vanhaecke (Contributor) & Gunda Köllensperger (Contributor)

  14 Aug 2017

  Activity: Talks and presentations › Talk or oral contribution › Science to Science

• Post-digestion stabilization of osmium enables quantitation by ICP-MS in cell culture and tissue

  Matthias Klose (Speaker), Michaela Hejl (Contributor), Petra Heffeter (Contributor), Michael Jakupec (Contributor), Samuel Matthias Meier (Contributor), Walter Berger (Contributor) & Bernhard Keppler (Contributor)

  17 May 2017

  Activity: Talks and presentations › Talk or oral contribution › Science to Science

• High resolution LA-ICP-MS imaging in three dimensional tumor spheroids

  Sarah Theiner (Speaker), S. Van Malderen (Contributor), T. Van Acker (Contributor), Anton Legin (Contributor), Michael Jakupec (Contributor), Bernhard Keppler (Contributor), Frank Vanhaecke (Contributor) & Gunda Köllensperger (Contributor)

  19 Feb 2017

  Activity: Talks and presentations › Talk or oral contribution › Science to Science

• Structure-activity relationship studies and biological activity of flavonol-derived RuII(arene) anticancer complexes

  Michael Jakupec (Contributor)

  7 Dec 2012

  Activity: Talks and presentations › Talk or oral contribution › Other

• Pt(IV) bis-, tris- and tetracarboxylato complexes as potentail anticancer drugs: synthesis, analytical, biological, DFT and QSAR studies.

  Michael Jakupec (Contributor)

  11 Oct 2012

  Activity: Talks and presentations › Talk or oral contribution › Other

• Cdk inhibitory activity of organometallic 3-(1H-benzimidazol-2-yl)-1H-pyrazolo[3,4-b]pyridines

  Michael Jakupec (Contributor)

  12 Sept 2012

  Activity: Talks and presentations › Talk or oral contribution › Other

• (Thio)pyronederived organometallics: an approach for new metalbased anticancer drugs

  Michael Jakupec (Contributor)

  18 Jun 2012

  Activity: Talks and presentations › Talk or oral contribution › Other

• DNA-binding and Topoisomerase IIa-inhibiting RuII(arene) Complexes with Flavone-derived Ligands

  Michael Jakupec (Contributor)

  2 Apr 2012

  Activity: Talks and presentations › Talk or oral contribution › Other

• Novel tetracarboxylato platinum(IV) complexes as carboplatin prodrugs

  Michael Jakupec (Contributor)

  2 Apr 2012

  Activity: Talks and presentations › Talk or oral contribution › Other

• Metal-Arene Complexes Linked with Carbohydrate Ligands: Cytotoxicity, Hydrolysis and Interaction with Biomolecules

  Michael Jakupec (Contributor)

  29 Mar 2010

  Activity: Talks and presentations › Talk or oral contribution › Other

• Maltol-derived ruthenium(II)-cymene complexes with tumor inhibiting properties: The impact of ligand-metal bond stability on the anticancer activity

  Michael Jakupec (Contributor)

  29 Mar 2010

  Activity: Talks and presentations › Talk or oral contribution › Other

• Synthesis and Cytotoxicity of Metal-Arene Complexes of 3-Hydroxy-2-pyridinone-Derived Ligands

  Michael Jakupec (Contributor)

  29 Mar 2010

  Activity: Talks and presentations › Talk or oral contribution › Other

• Organometallic anticancer compounds targeted by linking the flavopiridol backbone to ruthenium-cymene moieties

  Michael Jakupec (Contributor)

  29 Mar 2010

  Activity: Talks and presentations › Talk or oral contribution › Other

• Controlling the Reactivity of Anticancer Active Organometallic Compounds

  Michael Jakupec (Contributor)

  4 Feb 2010

  Activity: Talks and presentations › Talk or oral contribution › Other

• Pyrone-derived Ru(II) complexes and their biological activity

  Michael Jakupec (Contributor)

  25 Sept 2009

  Activity: Talks and presentations › Talk or oral contribution › Other

• Anticancer active RAPTA-C analogues with carbohydrate-based ligands: in vitro anticancer activity and metabolization

  Michael Jakupec (Contributor)

  11 Nov 2008

  Activity: Talks and presentations › Talk or oral contribution › Other

• Structure-activity relationships and DNA platination of new di- and tetracarboxylatoplatinum(IV) complexes

  Michael Jakupec (Contributor)

  19 May 2008

  Activity: Talks and presentations › Talk or oral contribution › Other

• Osmium(II)/(III)-dmso-azole complexes: synthesis, properties and application

  Michael Jakupec (Contributor)

  17 Mar 2008

  Activity: Talks and presentations › Talk or oral contribution › Other

• Tris(8-quinolinolato)gallium(III) (KP46, FFC11), an investigational anticancer drug in clinical trials

  Michael Jakupec (Invited speaker)

  15 Jul 2007

  Activity: Talks and presentations › Talk or oral contribution › Other

• XAS investigation of the Ga coordination sphere in solution and in cancer cells treated with KP46

  Michael Jakupec (Contributor)

  15 Jul 2007

  Activity: Talks and presentations › Talk or oral contribution › Other

• Novel strategies to develop new antitumor-active metal compounds

  Michael Jakupec (Contributor)

  4 Jul 2007

  Activity: Talks and presentations › Talk or oral contribution › Other

• Wechselwirkung cytotoxischer dinuklearer Ru(II)-Verbindungen mit Biomolekülen

  Michael Jakupec (Contributor)

  1 Jun 2007

  Activity: Talks and presentations › Talk or oral contribution › Other

• Modulating the in vitro activity of dinuclear ruthenium anticancer compounds. surprisingly high cytotoxicity and weak covalent DNA binding ability

  Michael Jakupec (Contributor)

  30 May 2007

  Activity: Talks and presentations › Talk or oral contribution › Other

• Preclinical and early clinical development of the antitumor gallium complex KP46 (FFC11)

  Michael Jakupec (Speaker)

  21 May 2006

  Activity: Talks and presentations › Talk or oral contribution › Other

• Redoxverhalten und Zytotoxizität der Rutheniumverbindung KP1019 in Gegenwart physiologischer Reduktionsmittel

  Michael Jakupec (Contributor)

  10 Apr 2006

  Activity: Talks and presentations › Talk or oral contribution › Other

• Synthese, Charakterisierung und antiproliferative Aktivität von 2,3-Diaminoglucopyranose-Platin(II)-Komplexen

  Michael Jakupec (Contributor)

  10 Apr 2006

  Activity: Talks and presentations › Talk or oral contribution › Other